Orthocell Limited (OCC.AX)
AUD 1.25
(-0.4%)
AUD 1.25
(-0.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -19.92 Million AUD | 17.86% |
| 2023 | -24.25 Million AUD | -130.7% |
| 2022 | -10.51 Million AUD | 33.06% |
| 2021 | -15.7 Million AUD | 21.23% |
| 2020 | -19.94 Million AUD | -77.47% |
| 2019 | -11.23 Million AUD | -286.1% |
| 2018 | -2.91 Million AUD | 42.33% |
| 2017 | -5.04 Million AUD | 2.62% |
| 2016 | -5.18 Million AUD | -8.54% |
| 2015 | -4.77 Million AUD | -37.69% |
| 2014 | -3.46 Million AUD | -486.55% |
| 2013 | -591.14 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -19.92 Million AUD | 17.86% |
| 2024 Q2 | -18.86 Million AUD | 0.0% |
| 2024 Q4 | -19.92 Million AUD | 0.0% |
| 2023 FY | -24.25 Million AUD | -130.7% |
| 2023 Q4 | -24.25 Million AUD | 0.0% |
| 2023 Q2 | -26.32 Million AUD | 0.0% |
| 2022 Q2 | -13.07 Million AUD | 0.0% |
| 2022 FY | -10.51 Million AUD | 33.06% |
| 2022 Q4 | -10.51 Million AUD | 0.0% |
| 2021 Q4 | -15.7 Million AUD | 0.0% |
| 2021 Q2 | -17.07 Million AUD | 0.0% |
| 2021 FY | -15.7 Million AUD | 21.23% |
| 2020 Q2 | -20.8 Million AUD | 0.0% |
| 2020 Q4 | -19.94 Million AUD | 0.0% |
| 2020 FY | -19.94 Million AUD | -77.47% |
| 2019 Q4 | -11.23 Million AUD | 0.0% |
| 2019 Q2 | -3.49 Million AUD | 0.0% |
| 2019 FY | -11.23 Million AUD | -286.1% |
| 2018 Q4 | -2.91 Million AUD | 0.0% |
| 2018 FY | -2.91 Million AUD | 42.33% |
| 2018 Q2 | -4.91 Million AUD | 0.0% |
| 2017 FY | -5.04 Million AUD | 2.62% |
| 2017 Q4 | -5.04 Million AUD | 0.0% |
| 2017 Q2 | -6.06 Million AUD | 0.0% |
| 2016 Q2 | -6.1 Million AUD | 0.0% |
| 2016 FY | -5.18 Million AUD | -8.54% |
| 2016 Q4 | -5.18 Million AUD | 0.0% |
| 2015 Q4 | -4.77 Million AUD | 0.0% |
| 2015 Q2 | -5.72 Million AUD | 0.0% |
| 2015 FY | -4.77 Million AUD | -37.69% |
| 2014 FY | -3.46 Million AUD | -486.55% |
| 2014 Q4 | -3.46 Million AUD | 0.0% |
| 2014 Q2 | -305.99 Thousand AUD | 0.0% |
| 2013 Q4 | -591.14 Thousand AUD | 0.0% |
| 2013 Q3 | -591.14 Thousand AUD | 0.0% |
| 2013 FY | -591.14 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -5.429% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -1928.776% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 493.2% |
| Biome Australia Limited | -1.56 Million AUD | -1174.933% |
| Patrys Limited | -2.24 Million AUD | -789.235% |
| Imugene Limited | -91.56 Million AUD | 78.239% |
| Noxopharm Limited | -2.31 Million AUD | -758.852% |
| PYC Therapeutics Limited | -65.76 Million AUD | 69.702% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -552.628% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -96.058% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -215.073% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -221.086% |
| CSL Limited | 15.76 Billion AUD | 100.126% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -56.71% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2708.051% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 89.111% |
| Starpharma Holdings Limited | -19.83 Million AUD | -0.468% |
| Nanollose Limited | -96.22 Thousand AUD | -20606.414% |
| Memphasys Limited | 4.13 Million AUD | 581.813% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -230.697% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -302.184% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -992.611% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 74.877% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1508.899% |
| Race Oncology Limited | -17.18 Million AUD | -15.917% |
| Nyrada Inc. | -4.76 Million AUD | -317.764% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 81.166% |
| Dimerix Limited | -21.99 Million AUD | 9.399% |
| PharmAust Limited | -9.71 Million AUD | -105.111% |
| Immutep Limited | -122.18 Million AUD | 83.694% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 85.404% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -59.655% |
| BTC Health Limited | -2.02 Million AUD | -885.322% |
| Acrux Limited | -1.45 Million AUD | -1266.581% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -16.56% |
| Biotron Limited | -386.06 Thousand AUD | -5060.942% |
| Tissue Repair Ltd | -16.44 Million AUD | -21.189% |
| AdAlta Limited | -845.17 Thousand AUD | -2257.476% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -7.266% |
| Hexima Limited | -2.22 Million AUD | -795.006% |
| AnteoTech Limited | -5 Million AUD | -298.374% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -13.328% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -486.689% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -273.876% |
| Actinogen Medical Limited | -9.13 Million AUD | -118.194% |
| Immuron Limited | -11.48 Million AUD | -73.503% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -25.213% |